Biogen Inc. shares spiked Tuesday after a report by the Wall Street Journal that Merck & Co. and Allergan PLC have each considered a takeover of the biotechnology company. “With the departure of their CEO, Biogen has put up a short-term ‘for sale’ sign, indicating to interested parties that now would be a time to show interest,” Geoffrey Porges, an...